Guided Therapeutics, Inc. Initiates Cervical Cancer Screening Trial For Luviva® Advanced Cervical Scan

AUGUSTA, Ga. & CUSCO, Peru--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it will begin enrollment this week in a multi-center clinical trial to expand claims for the LuViva® Advanced Cervical Scan to include front-line screening for cervical cancer.

The trial will be run by principal investigator, Dr. Daron G. Ferris, Director, HPV Prevention Program and Professor of Obstetrics and Gynecology at the Medical College of Georgia at Georgia Regents University in Augusta, Georgia. Dr. Ferris is the author of five peer-reviewed journal articles about LuViva and is the past-president of the American Society of Colposcopy and Cervical Pathology. The trial will take place at Georgia Regents University as well as CerviCusco, a Peruvian registered non-profit organization founded by Dr. Ferris, to address the exceedingly high rate of cervical cancer in rural Peru.

Help employers find you! Check out all the jobs and post your resume.